GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,000 | -99.9% | 51 | -99.9% | 0.00% | -100.0% |
Q2 2020 | $1,680,000 | +12.9% | 41,185 | +4.9% | 0.59% | -31.9% |
Q1 2020 | $1,488,000 | -13.9% | 39,272 | +6.8% | 0.87% | -26.8% |
Q4 2019 | $1,728,000 | +6.6% | 36,776 | -3.2% | 1.19% | -2.7% |
Q3 2019 | $1,621,000 | +8.9% | 37,978 | +2.1% | 1.22% | -3.8% |
Q2 2019 | $1,488,000 | +15.1% | 37,183 | +20.2% | 1.27% | +8.1% |
Q1 2019 | $1,293,000 | – | 30,932 | – | 1.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |